Back to mobile site
Get it on Google Play

Vivani Medical gets ethics approval for semaglutide implant trial

June 25, 2026 7:30 AM EDT Send to a Friend
Vivani Medical, Inc. (Nasdaq: VANI) announced it has received approval from Bellberry, a human research ethics committee (HREC) in Australia ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login